Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
Ventyx Biosciences (Nasdaq: VTYX), a clinical-stage biopharmaceutical company developing oral therapies for inflammatory diseases, has announced its participation in three major investor conferences. The company will present at the Stifel 2024 Healthcare Conference in New York on November 18, the Jefferies London Healthcare Conference on November 20, and the Piper Sandler Healthcare Conference in New York on December 4. Webcasts of all presentations will be available on the company's website for thirty days following each event.
Ventyx Biosciences (Nasdaq: VTYX), un'azienda biofarmaceutica in fase clinica che sviluppa terapie orali per malattie infiammatorie, ha annunciato la sua partecipazione a tre importanti conferenze per investitori. L'azienda presenterà alla Stifel 2024 Healthcare Conference a New York il 18 novembre, alla Jefferies London Healthcare Conference il 20 novembre, e alla Piper Sandler Healthcare Conference a New York il 4 dicembre. I webcast di tutte le presentazioni saranno disponibili sul sito web dell'azienda per trenta giorni dopo ciascun evento.
Ventyx Biosciences (Nasdaq: VTYX), una empresa biofarmacéutica en etapa clínica que desarrolla terapias orales para enfermedades inflamatorias, ha anunciado su participación en tres importantes conferencias de inversores. La empresa presentará en la Stifel 2024 Healthcare Conference en Nueva York el 18 de noviembre, en la Jefferies London Healthcare Conference el 20 de noviembre, y en la Piper Sandler Healthcare Conference en Nueva York el 4 de diciembre. Las retransmisiones de todas las presentaciones estarán disponibles en el sitio web de la empresa durante treinta días después de cada evento.
벤틱스 바이오사이언스 (Nasdaq: VTYX)는 염증 질환을 위한 경구 요법을 개발하는 임상 단계의 생명공학 회사로, 세 가지 주요 투자자 회의에 참여한다고 발표했습니다. 이 회사는 11월 18일 뉴욕에서 열리는 Stifel 2024 Healthcare Conference에서 발표할 예정이며, 11월 20일 Jefferies London Healthcare Conference, 12월 4일 뉴욕에서 열리는 Piper Sandler Healthcare Conference에서도 발표합니다. 모든 발표의 웹캐스트는 각 이벤트 후 30일 동안 회사 웹사이트에서 제공됩니다.
Ventyx Biosciences (Nasdaq: VTYX), une entreprise biopharmaceutique en phase clinique développant des thérapies orales pour les maladies inflammatoires, a annoncé sa participation à trois grandes conférences d'investisseurs. L'entreprise présentera à la Stifel 2024 Healthcare Conference à New York le 18 novembre, à la Jefferies London Healthcare Conference le 20 novembre, et à la Piper Sandler Healthcare Conference à New York le 4 décembre. Les rediffusions de toutes les présentations seront disponibles sur le site Web de l'entreprise pendant trente jours après chaque événement.
Ventyx Biosciences (Nasdaq: VTYX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das orale Therapien für entzündliche Erkrankungen entwickelt, hat seine Teilnahme an drei großen Investorenkonferenzen angekündigt. Das Unternehmen wird am 18. November auf der Stifel 2024 Healthcare Conference in New York, am 20. November auf der Jefferies London Healthcare Conference und am 4. Dezember auf der Piper Sandler Healthcare Conference in New York präsentieren. Die Webcasts aller Präsentationen sind auf der Website des Unternehmens für dreißig Tage nach jeder Veranstaltung verfügbar.
- None.
- None.
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:
| • | Event: Stifel 2024 Healthcare Conference |
| Location: New York, NY | |
| Date: Monday, November 18, 2024 | |
| Time: 4:10-4:40 PM ET | |
| • | Event: Jefferies London Healthcare Conference |
| Location: London, UK | |
| Date: Wednesday, November 20, 2024 | |
| Time: 8:00-8:25 AM GMT | |
| • | Event: Piper Sandler Healthcare Conference |
| Location: New York, NY | |
| Date: Wednesday, December 4, 2024 | |
| Time: 4:00-4:25 PM ET | |
A webcast of the presentations will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of each event for thirty days.
About Ventyx Biosciences
Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical needs with novel oral therapies that can shift inflammation and immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting NLRP3, S1P1R and TYK2, positioning us to become a leader in the development of oral immunology therapies for peripheral and neuroinflammatory diseases. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.
Investor Relations Contact
Joyce Allaire
Managing Director
LifeSci Advisors
jallaire@lifesciadvisors.com
FAQ
What investor conferences will Ventyx Biosciences (VTYX) attend in November-December 2024?
How can investors access Ventyx Biosciences (VTYX) conference presentations in 2024?
When is Ventyx Biosciences (VTYX) presenting at the Stifel Healthcare Conference 2024?
What time is Ventyx Biosciences (VTYX) presenting at the Jefferies London Healthcare Conference?
